Leukocytapheresis for the treatment of refractory Henoch-Schönlein purpura resistant to both prednisolone and intravenous immunoglobulin therapy.
Henoch-Schönlein purpura (HSP) is a childhood disorder, which is the vasculitis of systemic small vessels of unknown etiology. We encountered the dramatic efficacy of leukocytapheresis in a Japanese girl with refractory HSP resistant to combined prednisolone plus intravenous immunoglobulin therapy administration.
Eishin
E
Oki
Koji
K
Tsugawa
Koichi
K
Suzuki
Etsuro
E
Ito
Hiroshi
H
Tanaka
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002675:Child, Preschool; D005260:Female; D006801:Humans; D011695:IgA Vasculitis / Q000188:drug therapy / Q000628:therapy*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007937:Leukapheresis; D011239:Prednisolone / Q000627:therapeutic use; D017211:Treatment Failure
D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D011239:Prednisolone